Search PubMed⌕ Search

Biomedical subjects

J C Scotto

Publications and source records attributed to J C Scotto.

71 records · Page 4Linked to original sources
PubMedDate not supplied

[Erythrocyte membrane transport of tyrosine and tryptophan and plasma level of MHPG in depressive disorders].

Both plasma MHPG level and red blood cell membrane transports (TM) of L-tyrosine (L-TYR) and L-tryptophan (L-TRY) were evaluated in 29 depressed patients and compared to 16 control subjects. On the basis of MHPG plasmatic levels, we were able to define two subgroups in the depressed population showing a biological homogeneity: in the first one, both MHPG level and TYR TM decreased, while in the second one neither of these indices were disturbed. These biological features were not related to the nosographic subgroups. Bipolar depressed subjects showed a decrease in both MHPG and TYR TM; unipolar depressed subjects exhibited a decrease in both MHPG and TYR TM associated to an increase in TRY TM, whereas no change was found in dysthymic disorders. The time course of MHPG and MT were desynchronized if followed during the antidepressant treatment. At day 7, MHPG level increased significantly, while clinical improvement showed a normalisation of MHPG and TYR TM.

Adult↗
PubMedDate not supplied

[Plasma levels of metapramine and its 3 major metabolites in patients with depression. Results and preliminary interpretations].

Metapramine (Timaxel) and his three major metabolites (19148 RP, 23669 RP, 19749 RP) have been determined in the plasma of 18 depressed inpatients treated by the antidepressant drug (12 women and 6 men; 7 are smokers and 11 non-smokers). In a steady state, interindividual variability is very important, especially for 23669 RP. No significant correlation exists between normalized doses (mg.kg-1) and normalized plasma concentrations (ng.ml-1/dose mg.kg-1) of metapramine or anyone of its metabolites. The plasma metabolic ratios reveal also important intraindividual and interindividual variability. Two populations of patients seem to exist: extensive metabolizers and relatively poor metabolizers, without apparent clinical consequence because 23669 RP shows an antidepressant activity. Women seem, with equal normalized doses, to exhibit higher plasma levels of unchanged metapramine than men, due to a lower protein-binding rather than to a more active metabolism. In patients who received a poly-medication smoking seems not to induce desmethylation of metapramine. The plasma metabolic ratios, compared by the analysis of variance and the Wilcoxon distribution-free test, are significatively influenced by sex and not by tobacco-smoking.

Adult↗
PubMedDate not supplied

[Visual potentials evoked by a pattern reversal checkerboard in 50 depressed patients].

The pertinency of the visual evoked potentials (VEP) was studied as an index of depression in a group of 50 depressed patients (according to DSM III criteria). The VEP recordings were realized before an antidepressive treatment (D0) and 4 weeks after the beginning of the treatment (D28). Identical recordings were realized with 15 healthy and voluntary reference subjects. Stimulations were reversal checkerboard. The analysis of the results indicate at D0 a reduction of P1 and N1 latencies in the depressed people compared to the reference subjects, and an increase of the P1-N1 amplitude. These differences disappear at D28 (after the antidepressive treatment), as we don't notice any significative difference between D0 and D28 with the reference subjects. The interpretation of these results leads to the hypothesis of a neurophysiological modification of the attentional processes during the depression state. The antidepressive treatment seems merely to produce a normalization of the evoked responses in the depressed patients.

Adult↗
PubMedDate not supplied

[Multidisciplinary approach to depression. Preliminary results].

In the present study, clinical interview, Visual Evoked Potentials, psychological tests, TRH test, plasmatic MHPG dosage were investigated in 30 depressed patients with major depressive disorders. All the explorations were realised before and after 28 days of an antidepressant treatment. Thanks to analysis we found out the value of psychological tests. The study of evoked potentials brings to light the existence of electrophysiological variables, subordinate to the clinical state. On the contrary, "TRH Test" does not give us any useful indication, and plasmatic MOPEG dosage, although it confirms the existence of two groups of depressed patients, does not suggest any relationship with evolutive types.

Adult↗
PubMedDate not supplied

[Descriptive approach to latent forms of schizophrenia].

The computerized medical file, used in routine work in an Adult Psychiatry University-Hospital Unit enabled us to select 113 cases among 1,000 consecutive hospitalizations, the diagnosis of which could possibly lead to schizophrenia. These cases which we named "paraschizophrenic states" are linked to DSM III-R criteria of borderline (27 cases), schizoid (40 cases) or schizotypical (15 cases) personalities, schizophreniform trouble and unspecified psychotic trouble (17 cases), brief reactional psychosis (14 cases). We selected 196 cases of schizophrenia in the same cohort of hospitalized patients. As it is now usually admitted, we marked out two subgroups in this second group: the positive schizophrenia which gather together the paranoid and undifferentiated patterns and the negative schizophrenia which correspond to disorganized, catatonic and residual models, according to DSM III-R criterion. We compared the "paraschizophrenic states'" group and its five subgroups (we indeed joined schizophreniform trouble and unspecified psychotic trouble under the name of "other psychotic trouble" by reason of their relative nosographic lacks of precision and of their too small sizes) with the schizophrenia's group and its two subgroups. Each group is matched for sex (1.51 men for 1 woman in the first group and 1.45 men for 1 woman in the second group). We evaluated statistics for markers usually studied in schizophrenia in each subgroup. These markers are of three classes: biographical: age during the study, age of troubles' onset, season of birth; socioeconomic: socioeconomic level of family and patient's student status; psychiatric: family (history affective trouble, psychotic trouble, alcoholism), treatment response and short- and middle-term prognosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMedDate not supplied

[Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].

Our study focuses on psychometrics properties of the french version of the Positive and Negative Syndrom Scale (PANSS). 85 schizophrenic subjects, in accordance with DSM III-R criteria were included in this study. Our results allow us to discuss the construct validity and the reliability of this scale. The traditional 3 dimensions of the PANSS (positive, negative and general psychopathology) are discuss. We show that expect positive scale and general psychopathology scale average several symptomatic dimensions. We propose a 5 dimensions solution (negative, hostility, positive, disorganization, anxiety), which represent 54% of the total inertie. The internal consistency of this solution is presented.

Adolescent↗
PubMedDate not supplied

[Frontal lobe cognition disorders in 42 schizophrenic patients compared with 19 normal probands].

In schizophrenia, the hypothesis of frontal dysfunctions is sustained by various clinical, neuroradiological and neuropsychological observations. We have studied the degree of frontal cognitive impairment in 42 schizophrenic patients according to the DSM IV as compared to 19 normal subjects. Furthermore, the performances of the different tests were connected with the age, the duration of the disease, the severity of the illness (measured by the PANSS scale) and the incidence of the treatments. The neuropsychological tests used in this study were the D48, the Wisconsin card sorting test, the Stroop color and word test, the word fluency and a target detection test. The results obtained from this study agree with the occurrence of frontal cognitive impairments in schizophrenia. Such impairments are increased with the age and the duration of the disease.

Adolescent↗